Results 151 to 160 of about 153,871 (338)

Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters, Ji Yun Tark, Tiffany M. Chambers, Tania A. Desrosiers, Michael E. Scheurer, Charles Shumate, Wendy N. Nembhard, Mahsa M. Yazdy, Eirini Nestoridi, Amanda E. Janitz, Jean Paul Tanner, Russell S. Kirby, Jason L. Salemi, Yao Yu, Chad D. Huff, Sharon E. Plon, Philip J. Lupo, Jeremy M. Schraw   +17 more
wiley   +1 more source

EU CyberCars-2 Final Demo Results: IAI-CSIC Standpoint

, 2010
Javier Alonso, Centro de Automática y Robótica, UPM-CSIC, Carretera de Campo Real, km. 0.200, 28500 La Poveda, Arganda del Rey, Madrid, Spain, Joshué Perez, Vicente Milanés, Carlos González, Teresa de Pedro   +5 more
openalex   +1 more source

Supporting Survivor‐Centered Care Through Digital Health Integration

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak, Rebecca Williamson‐Lewis, Michael O'Connor, Michael Palgon, Yu‐Ra Kim, Michael Schuckenbrock, Paula Edwards, Abraham Mendoza, Anthony Adams, Brian Arriaga‐Solis, Justin Parker, Harry Tinoco‐Giraldo, Jason King, C. Michael Fordis, Karen E. Effinger, Maria Monica Gramatges   +15 more
wiley   +1 more source

Does it Make a Difference? Comparing Growth Effects of European and North American FDI in Latin America [PDF]

FDI from the European Union (EU) ranks before FDI from North America (NA) in some of the Latin American countries. We investigate the impact of EU- versus NA-FDI on the growth rate including about 50 controls.
Prüfer, Patricia, Tondl, Gabriele
core  

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Runaway electron beam formation, vertical motion, termination and wall loads in EU-DEMO

Nuclear Fusion
Runaway electron (RE) loads onto material structures are a major concern for future large tokamaks due to the efficient avalanching at high plasma currents.
F. Vannini, V. Bandaru, H. Bergström, N. Schwarz, F.J. Artola, M. Hoelzl, G. Pautasso, E. Nardon, F. Maviglia, M.L. Richiusa, E. Emanuelli, the JOREK Team   +11 more
doaj   +1 more source

Thermal-hydraulic optimization of a proposed EU-DEMO hydrogen passive removal system

, 2023
Tommaso Glingler, Gianfranco Caruso, Matteo D’Onorio   +2 more
openalex   +1 more source

Parametric scaling of power exhaust in EU-DEMO alternative divertor simulations [PDF]

, 2022
A. E. Järvinen, L. Aho-Mantila, T. Lunt, F. Subba, G. Rubino, L. Xiang   +5 more
openalex   +1 more source

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi, Daisuke Katagiri, Takeyuki Watadani, Shunichi Matsuda, Hiroshi Kaneko, Noritoshi Arai   +5 more
wiley   +1 more source

Global tungsten erosion and migration modeling for the EU-DEMO with the ERO2.0 code

Nuclear Fusion
Global tungsten migration, thus erosion, transport, and deposition, in the EU-DEMO tokamak is investigated using ERO2.0 simulations for an argon-seeded ELM-free H-mode plasma scenario with expected 2 GW fusion power developed with the narrow-grid version
C. Baumann, J. Romazanov, D. Matveev, A. Kirschner, F. Subba, S. Wiesen, S. Brezinsek, Ch. Linsmeier   +7 more
doaj   +1 more source